Amyris

^{, Nasdaq: AMRS}

Uses genetically modified yeast to make products for specialty chemical/fuel markets.

Industry: Energy

First Day Return: +3.1%

AMRS

Uses genetically modified yeast to make products for specialty chemical/fuel markets.

IPO News for Amyris

US IPO Index concludes January, second best month since 2009 02/01/12
Chemical conversion specialist Mascoma files for a $100 million IPO 09/16/11
Biochemicals maker Genomatica plans to go public 08/24/11

IPO Data
IPO Date	09/27/2010
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$85
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.amyris.com
Headquarters	Emeryville, CA, United States
Founded	2003
Employees at IPO	n/a

IPO News for Amyris

US IPO Index concludes January, second best month since 2009 02/01/12
Chemical conversion specialist Mascoma files for a $100 million IPO 09/16/11
Biochemicals maker Genomatica plans to go public 08/24/11

Amyris (AMRS) Performance